The changes of platelet-derived growth factor-BB (PDGF-BB) in T2DM and its clinical significance for early diagnosis of diabetic nephropathy

Diabetes Research and Clinical Practice

Volumn 85, Issue 2, 2009, Pages 166-170

  Wang, Qiu yue ^a   Guan, Qing hua ^a   Chen, Fen qin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Albuminuria; Diabetic nephropathy; Platelet derived growth factor BB

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NITROGEN; PLATELET DERIVED GROWTH FACTOR BB; TRIACYLGLYCEROL; UREA;

ADULT; ALBUMINURIA; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE DURATION; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION;

ADULT; AGED; ALBUMINURIA; ANALYSIS OF VARIANCE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET-DERIVED GROWTH FACTOR; REFERENCE VALUES;

EID: 67649859287     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.05.008     Document Type: Article

References (20)

1. Li X., Ponten A., Aase K., Karlsson L., Abramsson A., Uutela M., et al. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor [J]. Nat. Cell Biol. 2 5 (2000) 302-309
2. Bergsten E., Uutela M., Li X., Pietras K., Ostman A., Heldin C.H., et al. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor [J]. Nat. Cell Biol. 3 5 (2001) 512-516
3. Pietras K., Sjoblom T., Rubin K., Heldin C.H., and Ostman A. PDGF receptors as cancer drug targets [J]. Cancer Cell 3 5 (2003) 439-443
4. Ostendorf T., Kunter U., Van Roeyen C., Dooley S., Janjic N., Ruckman J., et al. The effects of platelet-derived growth factor in experimental glomerulonephritis are independent of the transforming growth factor-beta system. J. Am. Soc. Nephrol. 13 3 (2002) 658-667
5. Nakagawa H., Sasahara M., Haneda M., Koya D., Hazama F., and Kikkawa R. Immunohistochemical characterization of glomerular PDGF B-chain and PDGF beta-receptor expression in diabetic rats. Diabetes Res. Clin. Pract. 48 2 (2000) 87-98
6. Uehara G., Suzuki G., Toyoda M., Umezono T., and Sakai H. Glomerular expression of platelet-derived growth factor (PDGF)-A, B chain and PDGF receptor-alpha, -beta in diabetic nephropathy. Clin. Exp. Nephrol. 8 1 (2004) 36-42
7. Fagerudd J.A., Groop P.H., Honkanen E., Teppo A.M., and Gronhaqen-Riska C. Urinary excretion of TGF-β1, PDGF- BB and fibronectin in insulin-dependent diabetes mellitus patients. Kidney Int. 52 Suppl. 63 (1997) 195-197
8. Nishida Y., Oda H., and Yorioka N. Effect of lipoproteins on mesangial cell proliferation. Kidney Int. Suppl. 71 (1999 July) S51-S53
9. Schmitz A., Gundersen H.J., and Østerby R. Glomerular morphology by light microscopy in non-insulin-dependent diabetes mellitus. Diabetes 37 (1988) 38-43
10. Hayashi H., Karasawa R., Inn H., Saitou T., Ueno M., Nishi S., et al. An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus. Kidney Int. 41 (1992) 749-757
11. Steffes M.W., Østerby R., Chavers B., and Mauer S.M. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38 (1989) 1077-1081
12. Steffes M.W., Bilous R.W., Sutherland D.E., and Mauer S.M. Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes 41 (1992) 679-684
13. Taneda S., Hudkins K.L., Cui Y., Farr A.G., Alpers C.E., and Seqerer S. Growth factor expression in a murine model of cryoglobulinemia. Kidney Int. 63 2 (2003) 576-590
14. Tang W.W., Ulich T.R., Lacey D.L., Hill D.C., QI M., Kaufman S.A., et al. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am. J. Pathol. 148 4 (1996) 1169-1180
15. Langham R.G., Kelly D.J., Maguire J., Dowling J.P., Gilbert R.E., and Thomson N.M. Over-expression of platelet-derived growth factor in human diabetic nephropathy. Nephrol. Dial. Transplant. 18 7 (2003) 1392-1396
16. Wang S.N., and Hirschberg R. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis. Am. J. Physiol. Renal Electrolyte Physiol. 278 4 (2000) 554-560
17. Pantsulaia T. Role of TGF-beta in pathogenesis of diabetic nephropathy. Georgian Med. News 131 (2006 February) 13-18
18. Fraser D., Wakefield L., and Phillips A. Independent regulation of transforming growth factor-beta1 transcription and translation by glucose and platelet-derived growth factor. Am. J. Pathol. 161 3 (2002) 1039-1049
19. Fraser D., Brunskill N., Ito T., and Phillips A. Long-term exposure of proximal tubular epithelial cells to glucose induces transforming growth factor-β1 synthesis via an autocrine PDGF loop. Am. J. Pathol. 163 6 (2003) 2565-2574
20. Vieitez P., Gomez O., Uceda E.R., Vera M.E., and Molina-Holqado E. Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy. J. Renin Angiotensin Aldosterone Syst. 9 (2008) 96-102